275 related articles for article (PubMed ID: 27158847)
1. Interaction Between Alcohol Consumption Patterns, Antiretroviral Therapy Type, and Liver Fibrosis in Persons Living with HIV.
Bilal U; Lau B; Lazo M; McCaul ME; Hutton HE; Sulkowski MS; Moore RD; Chander G
AIDS Patient Care STDS; 2016 May; 30(5):200-7. PubMed ID: 27158847
[TBL] [Abstract][Full Text] [Related]
2. Impact of lifetime alcohol use on liver fibrosis in a population of HIV-infected patients with and without hepatitis C coinfection.
Fuster D; Tsui JI; Cheng DM; Quinn EK; Bridden C; Nunes D; Libman H; Saitz R; Samet JH
Alcohol Clin Exp Res; 2013 Sep; 37(9):1527-35. PubMed ID: 23647488
[TBL] [Abstract][Full Text] [Related]
3. Relationship between alcohol use categories and noninvasive markers of advanced hepatic fibrosis in HIV-infected, chronic hepatitis C virus-infected, and uninfected patients.
Lim JK; Tate JP; Fultz SL; Goulet JL; Conigliaro J; Bryant KJ; Gordon AJ; Gibert C; Rimland D; Goetz MB; Klein MB; Fiellin DA; Justice AC; Lo Re V
Clin Infect Dis; 2014 May; 58(10):1449-58. PubMed ID: 24569533
[TBL] [Abstract][Full Text] [Related]
4. The Role of Current and Historical Alcohol Use in Hepatic Fibrosis Among HIV-Infected Individuals.
Kim HN; Crane HM; Rodriguez CV; Van Rompaey S; Mayer KH; Christopoulos K; Napravnik S; Chander G; Hutton H; McCaul ME; Cachay ER; Mugavero MJ; Moore R; Geng E; Eron JJ; Saag MS; Merrill JO; Kitahata MM
AIDS Behav; 2017 Jul; 21(7):1878-1884. PubMed ID: 28035496
[TBL] [Abstract][Full Text] [Related]
5. Moderate Alcohol Use Is Not Associated With Fibrosis Progression in Human Immunodeficiency Virus/Hepatitis C Virus-Coinfected Women: A Prospective Cohort Study.
Kelly EM; Dodge JL; Bacchetti P; Sarkar M; French AL; Tien PC; Glesby MJ; Golub ET; Augenbraun M; Plankey M; Peters MG
Clin Infect Dis; 2017 Nov; 65(12):2050-2056. PubMed ID: 29020382
[TBL] [Abstract][Full Text] [Related]
6. Marijuana Use Is Not Associated With Progression to Advanced Liver Fibrosis in HIV/Hepatitis C Virus-coinfected Women.
Kelly EM; Dodge JL; Sarkar M; French AL; Tien PC; Glesby MJ; Golub ET; Augenbraun M; Plankey M; Peters MG
Clin Infect Dis; 2016 Aug; 63(4):512-8. PubMed ID: 27225241
[TBL] [Abstract][Full Text] [Related]
7. Impact of Alcohol and Coffee Intake on the Risk of Advanced Liver Fibrosis: A Longitudinal Analysis in HIV-HCV Coinfected Patients (ANRS HEPAVIH CO-13 Cohort).
Yaya I; Marcellin F; Costa M; Morlat P; Protopopescu C; Pialoux G; Santos ME; Wittkop L; Esterle L; Gervais A; Sogni P; Salmon-Ceron D; Carrieri MP;
Nutrients; 2018 May; 10(6):. PubMed ID: 29857547
[TBL] [Abstract][Full Text] [Related]
8. Is physician assessment of alcohol consumption useful in predicting risk of severe liver disease among people with HIV and HIV/HCV co-infection?
Shanyinde M; Girardi E; Puoti M; De Luca A; Sighinolfi L; Caterina UF; Caramello P; Lampe FC; D'Arminio Monforte A; Cozzi-Lepri A;
BMC Public Health; 2019 Oct; 19(1):1291. PubMed ID: 31615542
[TBL] [Abstract][Full Text] [Related]
9. Associations of Liver Disease with Alcohol Use among People Living with HIV and the Role of Hepatitis C: The New Orleans Alcohol Use in HIV Study.
Ferguson TF; Rosen E; Carr R; Brashear M; Simon L; Theall KP; Ronis MJ; Welsh DA; Molina PE
Alcohol Alcohol; 2020 Feb; 55(1):28-36. PubMed ID: 31812989
[TBL] [Abstract][Full Text] [Related]
10. Prognostic Value of the Fibrosis-4 Index in Human Immunodeficiency Virus Type-1 Infected Patients Initiating Antiretroviral Therapy with or without Hepatitis C Virus.
Mussini C; Lorenzini P; Puoti M; Lichtner M; Lapadula G; Di Giambenedetto S; Antinori A; Madeddu G; Cozzi-Lepri A; d'Arminio Monforte A; De Luca A;
PLoS One; 2015; 10(12):e0140877. PubMed ID: 26640953
[TBL] [Abstract][Full Text] [Related]
11. Liver fibrosis in HIV-infected individuals on long-term antiretroviral therapy: associated with immune activation, immunodeficiency and prior use of didanosine.
Kooij KW; Wit FW; van Zoest RA; Schouten J; Kootstra NA; van Vugt M; Prins M; Reiss P; van der Valk M;
AIDS; 2016 Jul; 30(11):1771-80. PubMed ID: 27088320
[TBL] [Abstract][Full Text] [Related]
12. Gender differences in liver fibrosis and hepatitis C virus-related parameters in patients coinfected with human immunodeficiency virus.
Collazos J; Cartón JA; Asensi V
Curr HIV Res; 2011 Jul; 9(5):339-45. PubMed ID: 21827383
[TBL] [Abstract][Full Text] [Related]
13. Zinc deficiency and advanced liver fibrosis among HIV and hepatitis C co-infected anti-retroviral naïve persons with alcohol use in Russia.
Barocas JA; So-Armah K; Cheng DM; Lioznov D; Baum M; Gallagher K; Fuster D; Gnatienko N; Krupitsky E; Freiberg MS; Samet JH
PLoS One; 2019; 14(6):e0218852. PubMed ID: 31246992
[TBL] [Abstract][Full Text] [Related]
14. Assessing mortality in women with hepatitis C virus and HIV using indirect markers of fibrosis.
Bambha K; Pierce C; Cox C; French AL; Tien PC; Sharp GB; Augenbraun M; Glesby MJ; Villacres MC; Plankey M; Strickler HD; Gange SJ; Peters MG
AIDS; 2012 Mar; 26(5):599-607. PubMed ID: 22156972
[TBL] [Abstract][Full Text] [Related]
15. Prevalence and predictors of liver disease in HIV-infected children and adolescents.
Pokorska-Śpiewak M; Stańska-Perka A; Popielska J; Ołdakowska A; Coupland U; Zawadka K; Szczepańska-Putz M; Marczyńska M
Sci Rep; 2017 Sep; 7(1):12309. PubMed ID: 28951598
[TBL] [Abstract][Full Text] [Related]
16. High Proportion of HIV-HCV Coinfected Patients with Advanced Liver Fibrosis Requiring Hepatitis C Treatment in Haiphong, Northern Vietnam (ANRS 12262).
Nguyen Truong T; Laureillard D; Lacombe K; Duong Thi H; Pham Thi Hanh P; Truong Thi Xuan L; Chu Thi N; Luong Que A; Vu Hai V; Nagot N; Tuaillon E; Dominguez S; Lemoine M
PLoS One; 2016; 11(5):e0153744. PubMed ID: 27148964
[TBL] [Abstract][Full Text] [Related]
17. HIV mono-infection is associated with FIB-4 - A noninvasive index of liver fibrosis - in women.
Blackard JT; Welge JA; Taylor LE; Mayer KH; Klein RS; Celentano DD; Jamieson DJ; Gardner L; Sherman KE
Clin Infect Dis; 2011 Mar; 52(5):674-80. PubMed ID: 21248367
[TBL] [Abstract][Full Text] [Related]
18. Liver fibrosis after antiretroviral therapy in a longitudinal cohort of sexually infected HIV patients in eastern China.
Wei Q; Lin H; Ding Y; Liu X; Wu Q; Shen W; Gao M; He N
Biosci Trends; 2017 Jul; 11(3):274-281. PubMed ID: 28484111
[TBL] [Abstract][Full Text] [Related]
19. Nonheavy Drinking and Worsening of Noninvasive Fibrosis Markers in Nonalcoholic Fatty Liver Disease: A Cohort Study.
Chang Y; Cho YK; Kim Y; Sung E; Ahn J; Jung HS; Yun KE; Shin H; Ryu S
Hepatology; 2019 Jan; 69(1):64-75. PubMed ID: 30019340
[TBL] [Abstract][Full Text] [Related]
20. Cocaine/crack use is not associated with fibrosis progression measured by AST-to-Platelet Ratio Index in HIV-HCV co-infected patients: a cohort study.
Martel-Laferrière V; Nitulescu R; Cox J; Cooper C; Tyndall M; Rouleau D; Walmsley S; Wong L; Klein MB;
BMC Infect Dis; 2017 Jan; 17(1):80. PubMed ID: 28095797
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
